Literature DB >> 16033817

Screening for dihydropyrimidine dehydrogenase deficiency.

Jean L Grem.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033817     DOI: 10.1158/1078-0432.CCR-05-0769

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  5 in total

1.  Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer.

Authors:  Mehdi Manoochehri; Ashraf Karbasi; Mojgan Bandehpour; Bahram Kazemi
Journal:  Pathol Oncol Res       Date:  2013-10-14       Impact factor: 3.201

2.  Overcoming 5-Fu resistance in human non-small cell lung cancer cells by the combination of 5-Fu and cisplatin through the inhibition of glucose metabolism.

Authors:  Jun-Gang Zhao; Kai-Ming Ren; Jun Tang
Journal:  Tumour Biol       Date:  2014-09-27

3.  Predictive markers for the response to 5-fluorouracil therapy in cancer cells: Constant-field gel electrophoresis as a tool for prediction of response to 5-fluorouracil-based chemotherapy.

Authors:  E M Saleh; R A El-Awady; N Anis
Journal:  Oncol Lett       Date:  2012-10-11       Impact factor: 2.967

4.  PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy.

Authors:  Jian Chen; Huijun Lu; Dongwang Yan; Feifei Cui; Xiaoliang Wang; Fudong Yu; Yingming Xue; Xiaodong Feng; Jingtao Wang; Xiao Wang; Tao Jiang; Meng Zhang; Senlin Zhao; Yang Yu; Huamei Tang; Zhihai Peng
Journal:  Oncotarget       Date:  2015-01-01

Review 5.  5-Fluorouracil: mechanisms of resistance and reversal strategies.

Authors:  Ning Zhang; Ying Yin; Sheng-Jie Xu; Wei-Shan Chen
Journal:  Molecules       Date:  2008-08-05       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.